Technical Analysis for TGTX - TG Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 7.97 2.18% 0.17
TGTX closed up 2.18 percent on Thursday, July 18, 2019, on 64 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical TGTX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Bullish Engulfing Bullish 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.18%
Wide Bands Range Expansion 2.18%
Down 3 Days in a Row Weakness 2.18%
20 DMA Resistance Bearish 1.14%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.14%
NR7 Range Contraction 1.14%
Inside Day Range Contraction 1.14%

Older signals for TGTX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
TG Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The company is developing two advanced therapies targeting hematological malignancies. The TGTX-1101 (ublituximab) is a novel, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes, which is in clinical development for patients with relapsed and refractory non-Hodgkin's lymphoma. The TGR-1202 is an orally available PI3K delta inhibitor believed to be important in the proliferation and survival of B-lymphocytes. TG Therapeutics, Inc. is headquartered in New York, New York.
Biopharmaceutical Cancer Treatment Of Cancer Monoclonal Antibodies Lymphoma Antibody Drug Conjugates Hematological Malignancies Camidanlumab Tesirine Cd20
Is TGTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.9
52 Week Low 3.32
Average Volume 1,509,772
200-Day Moving Average 6.1325
50-Day Moving Average 7.4582
20-Day Moving Average 7.972
10-Day Moving Average 8.078
Average True Range 0.416
ADX 20.11
+DI 21.5374
-DI 19.2098
Chandelier Exit (Long, 3 ATRs ) 8.132000000000001
Chandelier Exit (Short, 3 ATRs ) 8.058
Upper Bollinger Band 9.2292
Lower Bollinger Band 6.7148
Percent B (%b) 0.5
BandWidth 31.540391
MACD Line 0.1421
MACD Signal Line 0.215
MACD Histogram -0.0729
Fundamentals Value
Market Cap 496.61 Million
Num Shares 62.3 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -4.09
Price-to-Sales 3189.49
Price-to-Book 6.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.44
Resistance 3 (R3) 8.39 8.18 8.36
Resistance 2 (R2) 8.18 8.06 8.21 8.33
Resistance 1 (R1) 8.08 7.99 8.13 8.13 8.31
Pivot Point 7.87 7.87 7.90 7.90 7.87
Support 1 (S1) 7.77 7.75 7.82 7.82 7.63
Support 2 (S2) 7.56 7.68 7.59 7.61
Support 3 (S3) 7.46 7.56 7.58
Support 4 (S4) 7.51